Much has been made (rightly!) of the Affordable Care Act (ACA) provisions that have transformed health care for young Americans such as the provision that allows most young adults under 26 to remain on their parents’ health plans. As noted in a previous b

With today’s blog we welcome back “The Insider,” Community Catalyst Policy Director Michael Miller, who will continue to provide an “inside out” perspective on major policy and political developments in the health policy arena. Though today’s blog is very

This week marks the two year anniversary of the Affordable Care Act. And, while we will devote plenty of space this week to highlighting the many successes of the ACA, we could think of no better place to begin than with the law’s benefits for seniors. Un

Yesterday, the American Medical Student Association (AMSA) released their 2011-2012 PharmFree Scorecard, now in its fifth iteration. The Scorecard evaluates conflict-of-interest policies at the 152 medical schools in the U.S. and Puerto Rico, as well as a

Last week our old friend Laurie Martinelli (former Executive Director of Health Law Advocates) penned an op-ed in the Boston Globe nicely summing up both the opportunities and risks of new initiatives aimed at integrating care for dually eligible benefici

The American Medical Student Association (AMSA) will be releasing its fifth PharmFree Scorecard on Thursday, March 8. The PharmFree Scorecard measures how well academic medical institutions are doing at providing an educational (not promotional) environme

In the obscure pages of the Federal Register, consumers recently won an important victory -- a victory whose implications for Medicaid beneficiaries are anything but obscure. Last week, the Centers for Medicare & Medicaid Services (CMS) released a fin

Community Catalyst and 18 other consumer, patient safety and labor groups weighed in last week in support of (with important “friendly amendments”) draft regulations issued by the Centers for Medicare and Medicaid Services (CMS) requiring that the drug, b

Community Catalyst and 18 other consumer, patient safety and labor groups weighed in last week in support of (with important “friendly amendments”) draft regulations issued by the Centers for Medicare and Medicaid Services (CMS) requiring that the drug, b